MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Human Genome Sciences drops deep into the red
Human Genome Sciences Inc. (NSDQ:HGSI) reported losses of $87.6 million, or 46 cents per diluted share, on sales of $21.3 million during the three months ended Dec. 31, 2010. That compares with losses of $11.0 million, or 6 cents per diluted share, on sales of $53.0 million during the same period in 2009.

Full-year losses were $233.2 million, or $1.24 per diluted share, on sales of $157.4 million. That compares with profits of $5.7 million, or 4 cents per diluted share, on sales of $275.7 million in 2009.
Read more

Dyax remains in the red, but sales more than double
Dyax Corp. (NSDQ:DYAX) reported losses of $8.9 million, or 9 cents per diluted share, on sales of $9.3 million during the three months ended Dec. 31. That compares with losses of $10.9 million, or 14 cents per diluted share, on sales of $6.3 million during the same period last year.

Full-year losses were $24.5 million, or 26 cents per diluted share, on sales of $51.4 million. That compares with losses of $62.4 million, or 90 cents per diluted share, on sales of $21.6 million in 2009.
Read more

Teleflex Q4 profits almost double
Teleflex Inc. (NSDQ:TFX) reported profits of $81.1 million, or $2.01 per diluted share, on sales of $493.2 million during the three months ended Dec. 31, 2010. That compares with profits of $42.7 million, or $1.07 per diluted share, on sales of $486.2 million during the same period in 2009.

Full-year profits were $201.1 million, or $4.99 per diluted share, on sales of $1.80 billion. That compares with profits of $303.0 million, or $7.59 per diluted share, on sales of $1.77 billion in 2009.
Read more

Greatbatch rises out of the red on increased sales
Greatbatch Inc. (NYSE:GB) reported profits of $13.8 million, or 59 cents per diluted share, on sales of $133.1 million during the three months ended Dec. 31. That compares with a loss of $1.5 million, or 7 cents per diluted share, on sales of $125.8 million during the same period in 2009.

Full-year profits were $33.1 million, or $1.40 per diluted share, on sales of $533.4 million. That compares with losses of $9.0 million, or 39 cents per diluted share, on sales of $521.8 million in 2009.
Read more

Quidel profits turn to losses as sales fall 31 percent
Quidel Corp. (NSDQ:QDEL) reported losses of $426,000 or 2 cents per diluted share, on sales of $31.7 million during the three months ended Dec. 31. That compares with profits of $20.1 million, or 67 cents per diluted share, on sales of $66.6 million during the same period last year.

Full-year losses were $11.3 million, or 39 cents per diluted share, on sales of $113.3 million. That compares with profits of $32.9 million, or $1.08 cents per diluted share, on sales of $164.3 million in 2009.
Read more

VWR Funding
VWR Funding Inc. reported full-year profits of $21.5 million on sales of $3.64 billion. That compares with a loss of $14.1 million on sales of $3.56 billion in 2009.
Read more